申请人:——
公开号:US20040077675A1
公开(公告)日:2004-04-22
The present invention relates to a compound of formula (I), which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
1
本发明涉及一种式(I)的化合物,该化合物对于抑制由MRP1.1部分或全部赋予的耐药性肿瘤是有用的。